Mitesco (MITI) 10-Q 5 Dec 17 2017 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2017	Dec. 01, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	True Nature Holding, Inc.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		16,938,874
Amendment Flag	false
Entity Central Index Key	802,257
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Sep. 30, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q3

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Current assets
Cash and cash equivalents	$ 55	$ 0
Prepaid expenses and other current assets		1,875
Total current assets	55	1,875
Total Assets	55	1,875
Current liabilities
Accounts payable	698,632	589,229
Accrued liabilities	122,894	84,488
Due to related parties	55,303	106,866
Accrued interest	37,894	31,021
Convertible note payable, in default	256,270	256,270
Note payable - related party	75,000	0
Total current liabilities	1,245,993	1,067,874
Commitments and contingencies
Stockholders’ equity (deficit)
Preferred stock, $0.01 par value, 10,000,000 shares authorized, no shares issued or outstanding as of September 30, 2017 and December 31, 2016	0	0
Common stock, $0.01 par value, 500,000,000 shares authorized, 16,938,874 and 17,436,666 shares issued and outstanding as of September 30, 2017 and December 31, 2016	169,389	174,367
Additional paid-in capital	4,471,774	4,261,748
Stock payable	215,245	20,000
Accumulated deficit	(6,102,346)	(5,522,114)
Total (deficiency in) stockholders’ equity	(1,245,938)	(1,065,999)
Total liabilities and stockholders’ equity	$ 55	$ 1,875

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - $ / shares	Sep. 30, 2017	Dec. 31, 2016
Preferred stock, par value (in Dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in Dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	16,938,874	17,436,666
Common stock, shares outstanding	16,938,874	17,436,666

Unaudited Consolidated Statemen

Unaudited Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Revenue	$ 0	$ 0	$ 0	$ 0
Operating expenses:
General and administrative	121,589	2,143,463	564,086	4,655,818
Total operating expenses	121,589	2,143,463	564,086	4,655,818
Net Operating Loss	(121,589)	(2,143,463)	(564,086)	(4,655,818)
Other income (expense):
Interest expense	(10,434)	(109,919)	(20,256)	(174,857)
Gain on conversion of accrued interest	4,110	0	4,110	0
Gain (Loss) on debt extinguishment	0	(16,329)	0	(206,329)
Total other expense	(6,324)	(126,248)	(16,146)	(381,186)
Loss before provision for income taxes	(127,913)	(2,269,711)	(580,232)	(5,037,004)
Provision for income taxes	0	0	0	0
Net loss	$ (127,913)	$ (2,269,711)	$ (580,232)	$ (5,037,004)
Net loss per share - basic (in Dollars per share)	$ (0.01)	$ (0.17)	$ (0.03)	$ (0.40)
Net loss per share - diluted (in Dollars per share)	$ (0.01)	$ (0.17)	$ (0.03)	$ (0.40)
Weighted average shares outstanding - basic (in Shares)	17,640,776	13,203,132	18,025,704	12,653,300
Weighted average shares outstanding - diluted (in Shares)	17,640,776	13,203,132	18,025,704	12,653,300

Unaudited Consolidated Stateme5

Unaudited Consolidated Statements of Changes in Stockholders’ Deficit - 9 months ended Sep. 30, 2017 - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Stock Payable [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2016	$ 174,367	$ 4,261,748	$ 20,000	$ (5,522,114)	$ (1,065,999)
Balance (in Shares) at Dec. 31, 2016	17,436,666				17,436,666
Stock returned for cancellation by prior officer	$ (21,500)	21,500
Stock returned for cancellation by prior officer (in Shares)	(2,150,000)				2,150,000
Net loss				(580,232)	$ (580,232)
Sale of common stock, net of issuance costs	$ 3,000	44,000			$ 47,000
Sale of common stock, net of issuance costs (in Shares)	300,000				50,000
Stock issued for services	$ 5,836	103,874			$ 109,710
Stock issued for services (in Shares)	583,637
Stock committed to be issued for services			335,360		33,536
Stock issued for note extension	$ 150	1,350			1,500
Stock issued for note extension (in Shares)	15,000
Stock committed to be issued for note extension			5,523		5,523
Common stock issued for the conversion of payables	$ 2,286	29,714			32,000
Common stock issued for the conversion of payables (in Shares)	228,571
Stock committed to be issued for conversion of payables			76,986		76,986
Stock issued for conversion of accrued interest	$ 250	3,500			3,750
Stock issued for conversion of accrued interest (in Shares)	25,000
Stock issued to employees and directors as compensation	$ 5,000	6,088			11,088
Stock issued to employees and directors as compensation (in Shares)	500,000
Stock committed to be issued to employees and directors as compensation			79,200		79,200
Balance at Sep. 30, 2017	$ 169,389	$ 4,471,774	$ 215,245	$ (6,102,346)	$ (1,245,938)
Balance (in Shares) at Sep. 30, 2017	16,938,874				16,938,874

Unaudited Condensed Consolidate

Unaudited Condensed Consolidated Statement of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (580,232)	$ (5,037,004)
Adjustments to reconcile net loss to net cash used in operating activities:
Gain on conversion of accrued interest	(4,110)	0
Loss on extinguishment of debt	0	206,329
Debt discount amortization	0	157,947
Shares issued for extension of note payable	5,523	0
Stock based compensation	235,034	3,272,796
Changes in assets and liabilities:
Prepaid expenses	1,875	13,250
Accounts payable	218,389	514,757
Accrued liabilities	38,406	506,885
Due to related parties	23,437	77,284
Accrued interest	14,733	16,909
Net cash used in operating activities	(46,945)	(270,847)
CASH FLOWS FROM INVESTING ACTIVITIES
Proceeds from acquisition of business	0	0
Net cash provided by investing activities	0	0
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of convertible note payable	0	160,000
Sale of common stock, net of issuance costs	47,000	51,000
Repayment of promissory notes	0	(66,338)
Proceeds from promissory notes	0	98,000
Net cash provided by financing activities	47,000	242,662
Net increase (decrease) in cash and cash equivalents	55	(28,185)
Cash and cash equivalents at beginning of period	0	28,185
Cash and cash equivalents at end of period	55	0
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid	0	0
Income taxes paid	0	0
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Conversion of debt to common stock	0	103,671
Discount related to issuance of debentures, warrants and convertible notes	0	118,750
Stock committed to be issued for conversion of accounts payable	76,986	0
Par value of shares returned for cancellation	21,500	0
Stock issued for cash received in prior period	500	0
Note payable issued to related party for accounts payable to related party	75,000	0
Beneficial Conversion Feature	0	9,375
Notes Payable and Accrued Interest [Member]
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Conversion of debt to common stock	39,860	493,671
Accounts Payable [Member]
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Conversion of debt to common stock	$ 0	$ 390,000

Note 1 - Description of Busines

Note 1 - Description of Business	9 Months Ended
	Sep. 30, 2017
Disclosure Text Block [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	Note 1 – Description of Business True Nature Holding, Inc. (the “Company”), previously known as Trunity Holdings, Inc., became a publicly-traded company through a reverse merger with Brain Tree International, Inc., a Utah corporation (“BTI”). BTI was incorporated on July 26, 1983 to specialize in the development of high technology products or applications including, but not limited to, electronics, computerized technology, new technological product fields, and precious metals. Trunity Holdings, Inc. was the parent company of the prior educational business, named Trunity, Inc., which was formed on July 28, 2009 through the acquisition of certain intellectual property by its three founders. True Nature Holding, Inc. is a corporation organized under the laws of the state of Delaware with principal offices located in Atlanta, Georgia. On January 16, 2016, the Company changed the equity structure that included a reverse split of 1 for 101, such that all holders of 101 shares of common stock issued and outstanding prior to the effective date of the reverse split would own 1 share of common stock upon the effect date of the reverse split. In addition, the Company amended its Articles of Incorporation (i) to increase its authorized capital stock to 510,000,000 shares which consists of 500,000,000 shares of common stock, par value $0.01 per share, and 10,000,000 shares of preferred stock, par value $0.01 per share and (ii) to change its name from Trunity Holdings, Inc. to True Nature Holding, Inc. (there was no change in the stock symbol “TNTY”).

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2017
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	Note 2 – Summary of Significant Accounting Policies Basis of Accounting Use of Estimates - Comprehensive Loss – Cash - Revenue Recognition- Stock-Based Compensation - Equity instruments issued to those other than employees are recorded on the basis of the fair value of the instruments. In general, the measurement date is when either a (a) performance commitment, as defined, is reached or (b) the earlier of (i) the non-employee performance is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances of each particular grant. Convertible Instruments Common Stock Purchase Warrants- Stockholders’ Equity- Per Share Data- The Company has excluded all common equivalent shares outstanding for warrants, options and convertible instruments to purchase common stock from the calculation of diluted net loss per share because all such securities are antidilutive for the periods presented. As of December 31, 2016 and September 30, 2017, the Company had no outstanding warrants or options. Income Taxes- Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company has determined that a valuation allowance is needed due to recent taxable net operating losses, the sale of profitable divisions and the limited taxable income in the carry back periods. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or expense in the period that includes the enactment date. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and certain tax loss carryforwards, less any valuation allowance. The Company accounts for uncertain tax positions as required in that a position taken or expected to be taken in a tax return is recognized in the consolidated financial statements when it is more likely than not (i.e., a likelihood of more than fifty percent) that the position would be sustained upon examination by tax authorities. A recognized tax position is then measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. The Company does not have any material unrecognized tax benefits. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as components of interest expense and other expense, respectively, in arriving at pretax income or loss. The Company does not have any interest and penalties accrued. The Company is generally no longer subject to U.S. federal, state, and local income tax examinations for the years before 2012. Business Combinations- ● future expected cash flows from product sales, support agreements, consulting contracts, other customer contracts, and acquired developed technologies and patents; and ● discount rates utilized in valuation estimates. Unanticipated events and circumstances may occur that may affect the accuracy or validity of such assumptions, estimates or actual results. Additionally, any change in the fair value of the acquisition-related contingent consideration subsequent to the acquisition date, including changes from events after the acquisition date, such as changes in our estimates of relevant revenue or other targets, will be recognized in earnings in the period of the estimated fair value change. A change in fair value of the acquisition-related contingent consideration or the occurrence of events that cause results to differ from our estimates or assumptions could have a material effect on the consolidated financial position, statements of operations or cash flows in the period of the change in the estimate. Impairment of Long-Lived Assets- Financial Instruments and Fair Values- Level 1 – inputs include exchange quoted prices for identical instruments and are the most observable. Level 2 – inputs include brokered and/or quoted prices for similar assets and observable inputs such as interest rates. Level 3 – inputs include data not observable in the market and reflect management judgment about the assumptions market participants would use in pricing the asset or liability. The use of observable and unobservable inputs and their significant in measuring fair value are reflected in our hierarchy assessment. The carrying amount of cash, prepaid assets, accounts payable and accrued liabilities approximates fair value due to the short-term maturities of these instruments. Because cash and cash equivalents are readily liquidated, management classifies these values as Level 1. The fair value of the debentures, approximate their book value as the instruments are short-term in nature and contain market rates of interest. Because there is no ready market or observable transactions, management classifies the debentures as Level 3. Recently Issued Accounting Standards-

Note 3 - Financial Condition an

Note 3 - Financial Condition and Going Concern	9 Months Ended
	Sep. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Substantial Doubt about Going Concern [Text Block]	N ote 3 – Financial Condition and Going Concern As of September 30, 2017, the Company had cash on hand of $55 and current liabilities of $1,245,993 and has incurred a loss from operations. True Nature Holding’s principal operation is the acquisition of compounding pharmacy companies. The Company’s activities are subject to significant risks and uncertainties, including failing to secure additional funding to execute its business plan. As a result of these factors, there is substantial doubt about the ability of the Company to continue as a going concern. The Company’s continuance is dependent on raising capital and generating revenues sufficient to sustain operations. The Company believes that the necessary capital will be raised and has entered into discussions to do so with certain individuals and companies. However, as of the date of these consolidated financial statements, no formal agreement exists. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts classified as liabilities that might be necessary should the Company be forced to take any such actions.

Note 4 - Related Party Transact

Note 4 - Related Party Transactions	9 Months Ended
	Sep. 30, 2017
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	Note 4 – Related Party Transactions On January 25, 2016 two board members were each awarded 100,000 of shares of the Company’s common stock in exchange for their services as board members. The shares were valued at $145,000 based on the closing market price on the date of grant. On April 25, 2016 a board member was awarded 100,000 shares of the Company’s common stock in exchange for his services on the board and non-qualified stock options to purchase up to 1,000,000 shares of the Company’s common stock in consideration for his services as CEO. The stock options were subsequently cancelled in conjunction with his resignation as CEO on September 23, 2016, and 100,000 shares of restricted common stock valued at $47,680, based on the closing market price on the date of grant, in conjunction with the cancellation of all amounts owed as of the date of his resignation. On May 25, 2016, a board member was awarded 100,000 shares of the Company’s common stock, valued at $235,000 based on the closing market price on the date of grant, in exchange for his service as a member of the board. On September 23, 2016, the Company appointed three new directors to the Board of Directors, and each received 100,000 shares of common stock, each valued at $27,990 based on the closing market price on the date of grant, in conjunction with their appointments. On September 27, 2016, the Company accepted the resignations of its former Chairman and CFO and former CEO. The former CFO had a consulting agreement in the amount of $10,000 per month for professional fees. The Company’s former CEO had an employment agreement effective June 7, 2016 pursuant to which he received a monthly salary in the amount of $12,500 per month for the remainder of the 2016 calendar year, $17,500 per month for the 2017 calendar year, $22,500 per month for the 2018 calendar year and $25,000 per month for the 2019 calendar year. No payments have been made to the former CEO. Both of these agreements were cancelled and the Company has no further obligation to either individuals going forward. Further, the former CFO has agreed to return for cancellation 2,000,000 shares of restricted common stock of the Company, and to use 100,000 shares of Company common stock to settle an obligation to a former employee. The former CEO had been awarded options for the purchase of 1,000,000 shares of restricted common stock, which were all cancelled in conjunction with his resignation. In addition, the Company had a consulting agreement with a shareholder in the amount of $10,000 per month for professional fees. The shareholder and the Company have agreed to terminate the agreement as of September 30, 2016. In consideration of all amounts owed, the Company issued 966,666 shares of common stock, valued at $290,000 based on the closing market price on the date of grant, and the consultant cancelled $290,000 in amounts owed. The amounts owed consist of a) $80,000 in advances to the Company, or obligations paid to the Company, b) $120,000 in consulting fees owed and c) reimbursement of $90,000 of costs related to the formation of Newco4pharmacy, LLC, which was acquired by the Company in December 2015. On December 30, 2016, the Board of Directors of the Company issued 100,000 shares of restricted common stock to a consultant, who subsequently became the CEO and CFO of the Company as compensation for his contribution during the prior 90 days. The charge to earnings for this issuance was $19,080. On December 30, 2016, the Board voted to issue 100,000 shares of common stock to each of the Company’s Board members as additional compensation for services during the prior 90 days. Each of the recipients abstained from the vote on their issuance so as not to be voting on their own issuance; however, each member of the Board voted for the issuance of shares to their fellow Board members. The charge to earnings for this issuance was $19,080, for each of the three directors, or a total of $57,240. The Company had accounts payable from related party transactions of $106,866 as of December 31, 2016. The balance was made up of the following: a) two members of the Board of Directors were due $12,000 each for compensation expense that had not been paid; b) the former CEO and CFO of the Company were owed for reimbursable expenses that totaled $75,866; and c) a shareholder paid for expenses of the Company directly to several vendors in the aggregate amount of $7,000. On January 24, 2017, the Board granted to a member of Board of Directors 25,000 shares of restricted common stock as consideration for services. The member of the Board of Directors abstained from the vote as to not be voting on his own issuance. The value for the issuance was $3,500, based on the closing price on the date of the grant. On January 25, 2017, the Board granted the newly appointed CEO and CFO 500,000 shares of restricted common stock as part of his employment compensation. The shares are subject to reverse vesting that requires the executive to remain with the Company for three years (shares vest 1/3 per year) and achieve certain management objectives. Effective July 7, 2017, the executive resigned and 400,000 of the shares were cancelled (see Note 10). The expense to the Company was $15,236 during the nine months ended September 30, 2017. On February 7, 2017, the Board appointed one additional member to the Board of Directors. The directed received the customary 100,000 shares of restricted common stock for his service. The cost to the Company for this issuance was $11,000, based on the closing price on the date of the grant. The director offered to purchase 200,000 shares of restricted common stock at the same time. The consideration for the sale was $22,000. The transaction had no impact on earnings as the shares were priced at the same cost as the closing price on the date of the purchase. On February 14, 2017, the Board of Directors authorized the issuance of restricted common stock to convert amounts owed to a shareholder for consulting services. A total of $36,210 of accounts payable was converted at a price of $0.14 per share into 258,637 shares of the Company’s common stock. This calculation is based on the closing price of the Company’s common stock on the date of the grant. On February 14, 2017, the Board of Directors authorized the issuance of restricted common stock to convert amounts owed to a vendor. A total of $20,000 of accounts payable was converted at a price of $0.14 per share into 142,857 shares of the Company’s common stock. This calculation is based on the closing price of the Company’s common stock on the date of the grant. On February 14, 2017, the Board authorized the issuance of restricted shares of common stock in consideration for the conversion of the prior three month’s salary ($4,000 per month for a total of $12,000) of 2016 owed to a director serving as the Company’s Interim President. The Company issued the director 85,714 shares of common stock at $0.14 per share. The issuance of the foregoing shares was in settlement of all outstanding past debts owed to the director by the Company until February 14, 2017. As the conversion amount equals the share value, no gain or loss was recorded. On February 14, 2017, the Board granted the newly appointed COO 500,000 shares of restricted common shares as part of his employment compensation. The shares are subject to reverse vesting which requires the executive to remain with the Company for three years (shares vest 1/3 per year) and achieve certain management objectives. The expense to the Company was $11,088. On March 8, 2017, the Board authorized the issuance of 100,000 restricted common stock to a newly appointed member of the non-executive Advisory Board. The stock was priced at the closing price of the stock at that date which was $0.30. The expense to the Company was $30,000. On March 8, 2017, the Board authorized the issuance of 100,000 restricted common stock to an advisor with experience in retail pharmacy operations. The stock was priced at the closing price of the stock at that date which was $0.30. The expense to the Company was $30,000. On April 28, 2017, the Board granted the newly appointed Director of Corporate Communications 500,000 shares of restricted common shares as part of his employment compensation. The shares are subject to reverse vesting that requires the executive to remain with the Company for three years (shares vest 1/3 per year) and achieve certain management objectives. Effective August 1, 2017, the executive resigned and as a result 400,000 of the 500,000 shares were cancelled. The Company charged to operations the amount of $48,000 representing the fair value of 100,000 shares of common stock during the nine months ended September 30, 2017. On July 7, 2017, the Company accepted the resignation of its CEO, who also held the positions of interim CFO and interim Secretary. At the time of his hire, the CEO was granted 500,000 restricted shares as part of his executive compensation plan. The shares were issued subject to reverse vesting conditions. At July 7, 2017, 100,000 shares of restricted common stock have vested and the remaining 400,000 restricted shares will be canceled. The CEO has not been paid any cash compensation. During his tenure at the Company, he accrued $33,333 in salary, which will only be paid after the Company has sufficient financing to support its operations. Dr. Jordan Balencic, the Chairman of the Board of Directors, will assume the role of interim CEO and interim CFO until a successor is appointed. On July 10, 2017, the Company entered into an agreement with a related party whereby the amount of $75,000 in accounts payable due to the related party for services performed was converted to a note payable. The note payable is due 90 days from the date the Company receives funding in the amount of $1,000,000. The note is non-interest bearing unless it is not paid when due, at which time it will accrue interest at the rate of 12% per annum. On August 10, 2017, the Company issued 500,000 shares of restricted common stock, subject to reverse vesting conditions, to the Company’s Chief Operating Officer in conjunction with his engagement effective as of February 14, 2017. On August 10, 2017, the Company cancelled 2,150,000 shares of common stock previously held by its former Chief Executive Officer. The par value of these shares in the amount of $21,500 was charged to additional paid-in capital on the Company's balance sheet at September 30, 2017. On August 7, 2017, the Company committed to issue 25,000 shares of common stock to a lender for the extension of the term of a note payable. The fair value of these shares in the amount of $3,573 was charged to interest expense during the three months ended September 30, 2017, and is reported as stock payable on the Company's balance sheet at September 30, 2017. On August 23, 2017, the Company committed to issue 30,000 shares of common stock to a consultant for services. The fair value of these shares in the amount of $2,700 was charged to operations during the three months ended September 30, 2017, and is reported as stock payable on the Company's balance sheet at September 30, 2017. On September 26, 2017, the Company committed to issue 25,000 shares of common stock to a lender for the extension of the term of a note payable. The fair value of these shares in the amount of $1,950 was charged to interest expense during the three months ended September 30, 2017, and is reported as stock payable on the Company's balance sheet at September 30, 2017. On September 26, 2017, the Company committed to issue 200,000 shares of common stock to an employee as compensation. The fair value of these shares in the amount of $15,600 was charged to operations during the three months ended September 30, 2017, and is reported as stock payable on the Company's balance sheet at September 30, 2017. On September 26, 2017, the Company committed to convert accounts payable due to a consultant to the Company in the amount of $76,986 into 987,000 shares of common stock. The amount of $76,986 is reported as stock payable on the Company's balance sheet at September 30, 2017 On September 26, 2017, the Company committed to issue 200,000 shares of common stock to each of two board members, or an aggregate of 400,000 shares, for services performed. The fair value of $31,200 was charged to operations during the three months ended September 30, 2017.

Note 5 - Debt

Note 5 - Debt	9 Months Ended
	Sep. 30, 2017
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	Note 5 – Debt On March 18, 2016, the Company issued a 12% Convertible Promissory Note (the “Convertible Note A”) in the principal amount of $60,000 to a lender. Upon issuance of the Convertible A Note, the lender was awarded 15,000 restricted common stock as an origination fee which includes piggy back registration rights. On September 19, 2016, the Company issued the lender an additional 15,000 restricted common stock at a price of $0.30 per share to extend the term of the loan agreement indefinitely. The cost to the Company was $4,050 in interest expense. On August 10, 2017, the Company issued 25,000 shares of common stock with a fair value of $3,750 for accrued interest through August 1, 2017 in the amount of $7,860. The Company recognized a gain in the amount of $4,110 on this transaction. Accrued interest at September 30, 2017 and December 31, 2016, was $1,200 and $3,660, respectively. Pursuant to the terms of the Convertible Note A, the Company is obligated to pay monthly installments of not less than $1,000 the first of each month commencing the month following the execution of the Convertible Note A until its maturity on September 16, 2016 at which time the Company is obligated to repay the full principal amount of the Convertible Note A. The Convertible Note A is convertible by the holder at any time into shares of the Company’s common stock at price of $1.00 per share, and throughout the duration of the note, the holder has the right to participate in any financing the Company may engage in upon the same terms and conditions as all other investors. The Company allocated the face value of the Convertible Note A to the shares and the note based on relative fair values, and the amount allocated to the shares of $18,750 was recorded as a discount against the note. The beneficial conversion feature of $9,375 was recorded as a debt discount with an offsetting entry to additional paid-in capital decreasing the note payable and increasing debt discount. The debt discount is being amortized to interest expense over the term of the debt. For the year ended December 31, 2016, debt discount amortization related to the Convertible Note A was $28,125. There was no amortization of the discount during the 9 months ended September 30, 2017. On May 19, 2016, the Company issued a 10% Convertible Promissory Note (the “Convertible Note B”) in the principal amount of $100,000 to a lender. Upon issuance of the Convertible Note B, the lender was awarded 24-month warrants to purchase up to 66,666 shares of the Company’s common stock at an exercise price of $2.50 per share. The warrants were valued at $103,086 with $100,000 as a debt discount; the additional $3,086 was expensed as additional interest expense. The debt discount was fully amortized during the year ended December 31, 2016. This obligation, including all warrants, penalties and interest due was cancelled as of September 30, 2016 in consideration of the issuance of 400,000 shares of restricted common stock valued at $120,000. At the time of conversion, the principal amount of the note was approximately $100,000 and total accrued interest thereon was $3,671. Therefore, as a result of the conversion, a loss of $16,329 recognized in the nine months ended September 30, 2016. August 2014 Convertible Debentures (Series C) As part of the restructuring all debentures issued by Trunity Holdings, Inc., to fund the former, educational business were eligible to participate in a debt conversion; however, one debenture holder that was issued a Series C Convertible Debenture (the “Series C Debenture”) in August 2014 with an aggregate face value of $100,000 in exchange for the cancellation of Series B Convertible Debentures with a carrying value of $110,833 did not convert such debenture. The Series C Debenture accrues interest at an annual rate of 10%, matured November 2015, and is convertible into our common stock at a conversion rate of $20.20 per share. The holders of the Series C Debenture also received five year warrants to acquire up to 4,950 shares post-split of common stock for an exercise price of $20.20 per share,. The former educational business allocated the face value of the Series C Debenture to the warrants and the debentures based on its relative fair values, and allocated to the warrants, which was recorded as a discount against the Series C Debenture, with an offsetting entry to additional paid-in capital. The discount was fully expensed upon execution of the new debentures as debt extinguishment costs within discontinued operations. As of September 30, 2017 and December 31, 2016, the carrying value of this Series C Debenture was $110,833 and accrued interest expense of $32,733 and $24,420, respectively. The Series C Debenture is currently in default. November 2014 Convertible Debentures (Series D) As part of the restructuring all debentures issued by Trunity Holdings, Inc., to fund the former, educational business were eligible to participate in a debt conversion; however, one debenture holder that was issued a Series D Convertible Debenture (the “Series D Debenture”) in November 2014 with an aggregate face value of $10,000 in exchange for the cancellation of Series B Convertible Debenture with a carrying value of $11,333 did not participate in the debt conversion restructuring. The Series D Debenture accrues interest at an annual rate of 12%, matured November 2015, and is convertible into our common stock at a conversion rate of $16.67 per share. The holders of the Series D Debenture also received five year warrants to acquire up to 495 shares of common stock for an exercise price of $20.20 per share on a post-split basis. The former educational business allocated the face value of the Series D Debenture to the warrants and the debentures based on their relative fair values, and allocated to the warrants, which was recorded as a discount against the Series D Debenture, with an offsetting entry to additional paid-in capital. The discount was fully expensed upon execution of the new debentures as debt extinguishment costs within discontinued operations. As of September 30, 2017 and December 31, 2016, the carrying value of the Series D Debenture was $11,333 and accrued interest expense of $3,961 and $2,941, respectively. The Series D Debenture is currently in default. Short term loan As a result of the acquisition of P3 Compounding of Georgia, LLC (“P3”) the Company had a short-term convertible note with a loan agency in the principal amount of $52,000 for the purchase of future sales and credit card receivables of P3. Under the terms of the receivable purchase agreement, the Company purchased an advance of $50,000 plus $2,000 for origination costs with a 10.5% daily interest rate to be repaid over 160 days at a repayment amount of $451.75 per day. Upon maturity, the total repayment amount will be $72,280. As of December 31, 2016 the carrying value of this short-term loan was $26,925. For year ending December 31, 2016, no interest expense related to this loan was recorded in the Company’s consolidated financial statements as the effective date of acquisition was the last day of the quarter. The origination fee and interest were recorded as debt discount on the date of issuance in the amount of $22,280 and $22,280 was amortized during the year ending December 31, 2016. Although the note is in default, the lender and the Company have agreed not to take any action until such time as repayment can be arranged. July 2017 Note On July 10, 2017, the Company negotiated the reclassification of $75,000 in accounts payable to a loan payable (the “July 2017 Note”). The July 2017 Note is due no later than 90 days after the receipt of a minimum of $1,000,000 of funding. The July 2017 Note bears no interest; however, if it is not paid by the due date, interest will accrue at the rate of 12% per year.

Note 6 - Stockholders' Deficit

Note 6 - Stockholders' Deficit	9 Months Ended
	Sep. 30, 2017
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	Note 6 – Stockholders’ Deficit Sale of Common Stock During the nine months ending September 30, 2017, the Company raised gross proceeds of $47,000 through the sale of 250,000 shares of common stock to a new member of the Board of Directors and a third party investor at a price of $0.11 per share. Shares for Stock Based Compensation During the nine months ending September 30, 2017, in connection with services rendered, the Company issued 1,083,637 restricted shares of the Company’s common stock valued at $123,498 in exchange for services conducted on behalf of the Company. The value of these shares was based on the closing market price on the respective date of grant. The Company also has an additional 1,230,000 shares to be issued valued at $112,736 included in stock payable. Shares issued for convertible note payable issuance During the nine months ending September 30, 2017, in connection with a convertible promissory note, the Company issued 15,000 shares of the Company’s common stock with a fair value of $1,500 that was valued based on the closing market price on the date of the grant. The Company also committed to issue an additional 50,000 shares with a value of $5,523. The shares were issued in consideration of the extension of the due date of the loan. The Company also issued 25,000 shares of common stock with a fair value of $3,750 for the conversion of accrued interest in the amount of $7,860. The Company recorded a gain in the amount of $4,110 on this transaction. Shares issued for conversion of accounts payable During the nine months ending September 30, 2017, the Company converted several accounts payable amounts to shares of common stock. The Company issued 228,571 shares of common stock valued at $32,000 to settle the outstanding accounts payable. The Company also committed to issue 987,000 shares of common stock valued at $76,986 to settle additional outstanding accounts payable. Shares issued for conversion of debt Debt beneficial conversion feature for convertible note payable Stock payable for debt Stock returned for cancellation

Note 7 - Stock Options

Note 7 - Stock Options	9 Months Ended
	Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	Note 7 – Stock Options A summary of options issued, exercised and cancelled are as follows: Shares Weighted- Average Exercise Price ($) Weighted- Average Remaining Contractual Term Aggregate Intrinsic Value ($) Outstanding at December 31, 2016 67,879 $ 21.40 6.17 — Granted — — — — Cancelled — — — — Outstanding at September 30, 2017 67,879 $ 21.40 5.42 — Exercisable at September 30, 2017 67,879 $ 21.40 5.42 —

Note 8 - Stock Warrants

Note 8 - Stock Warrants	9 Months Ended
	Sep. 30, 2017
Disclosure Text Block Supplement [Abstract]
Shareholders' Equity and Share-based Payments [Text Block]	Note 8 – Stock Warrants Subsequent to the restructuring of the Company and the spin-out, the Company had warrants to purchase common stock outstanding that were not terminated and have continued as part of the operations as detailed below. The warrants were adjusted for a 1 for 101 stock split due to the spin-out and restructuring plan as authorized. All warrants outstanding as of September 30, 2017 are scheduled to expire at various dates through 2019. A summary of warrants issued, exercised and expired are as follows: Shares Weighted- Average Exercise Price ($) Weighted- Average Remaining Contractual Term Outstanding at December 31, 2016 142,653 $ 17.42 2.25 Granted — — — Expired — — — Outstanding at September 30, 2017 142,653 $ 17.42 1.50 Exercisable at September 30, 2017 142,653 $ 17.42 1.50

Note 9 - Commitments and Contin

Note 9 - Commitments and Contingencies	9 Months Ended
	Sep. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Note 9 – Commitments and Contingencies Legal National Council for Science and the Environment, Inc. v. Trunity Holdings, Inc., Case No. 2015 CA 009726 B, Superior Court for the District of Columbia, Civil Division. This action was filed on December 16, 2015 by the National Council for Science and the Environment, Inc. (“NCSE”) in the state court in the District of Columbia against Trunity Holdings, Inc. (“Trunity”) and alleges claims for breach of contract. Acknowledgement of indebtedness and settlement agreement and quantum meruit arising out of an agreement entered into between NCSE and Trunity in 2014. The complaint seeks damages in the amount of $177,270, inclusive of attorney’s fees, costs and accrued interest, continuing interest in the amount of 12% per annum and attorney’s fees and costs of collection relating to the case. The Company, in its answer dated January 27, 2016, denied the material allegations made by NCSE, asserted a number of affirmative defenses and filed a counterclaim alleging claims for fraud, negligent misrepresentation, breach of fiduciary duty, breach of contract and unjust enrichment. In its counterclaim, the Company sought actual and compensatory damages against NCSE that it believes exceed the amount sought by NCSE on its claims, pre-judgment interest, punitive damages and all costs and expenses, including attorney’s fees, incurred by the Company in bringing its claims against NCSE. On September 23, 2016, the Company settled this obligation with an agreement to pay $48,500 to NCSE if paid by November 4, 2016, and $75,000 if paid later. The Company has not paid the amounts as of the date of this filing, and has recorded the obligation at $75,000. Carlton Fields Jorden Burt, P.A. vs. True Nature Holding, Inc., f/k/a/ Trunity Holdings, Inc. This action was filed on May 18, 2017 by a law firm that represented the Company prior to the spin-out of the educational software business in 2016 with the intent of collection past due invoices in the aggregate amount of $241,828. The Company believes it has strong defenses against any such action and anticipates a settlement upon completion of certain funding activities. The Company has recorded a liability in the amount of $241,828 on its balance sheet at September 30, 2017. 230 Commerce Way, LLC vs. Trunity, Inc. A former landlord of the Company has filed an action in New Hampshire to collect on rent from a lease that existed prior to 2013. While this is an obligation of the spin-out business, and not the Company, we expect to expend approximately $20,000 to defend ourselves in this action. Trunity, Inc. The spin-out that now owns the former educational software business has been informed that they owe the Company from the obligations of the NCSE settlement, and the costs of the legal action. We intend to take all actions available to us to collect on these amounts.

Note 10 - Subsequent Events

Note 10 - Subsequent Events	9 Months Ended
	Sep. 30, 2017
Subsequent Events [Abstract]
Subsequent Events [Text Block]	Note 10 – Subsequent Events On September 27, 2017, the Board appointed Thomas Burnell as President and Chief Executive Officer of the Company effective as of October 2, 2017. On November 19, 2017 the Chairman of the Board of the Company and Mr. Burnell agreed that it was in the best interest of both parties to terminate his employment agreement, and on November 29, 2017, the Company and Mr. Burnell agreed on definitive terms for his termination agreement. Mr. Burnell shall be issued 80,000 shares of restricted common stock that had been agreed upon in conjunction with his hiring, but will not receive any other consideration, compensation or expense reimbursement. The Chairman of the Board reported that the scope of the responsibilities of the job exceeded Mr. Burnell's expectations, and there were no conflicts associated with his departure. We evaluated subsequent events after the balance sheet date through the date the financial statements were issued. Other than the events described above, we did not identify any additional material events or transactions which occurred during this subsequent event reporting period that required further recognition or disclosure in these financial statements.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	9 Months Ended
	Sep. 30, 2017
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Accounting Use of Estimates -
Comprehensive Income, Policy [Policy Text Block]	Comprehensive Loss –
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash -
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition-
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation - Equity instruments issued to those other than employees are recorded on the basis of the fair value of the instruments. In general, the measurement date is when either a (a) performance commitment, as defined, is reached or (b) the earlier of (i) the non-employee performance is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances of each particular grant.
Convertible Instruments, Policy [Policy Text Block]	Convertible Instruments
Warrants, Policy [Policy Text Block]	Common Stock Purchase Warrants-
Stockholders' Equity, Policy [Policy Text Block]	Stockholders’ Equity-
Earnings Per Share, Policy [Policy Text Block]	Per Share Data- The Company has excluded all common equivalent shares outstanding for warrants, options and convertible instruments to purchase common stock from the calculation of diluted net loss per share because all such securities are antidilutive for the periods presented. As of December 31, 2016 and September 30, 2017, the Company had no outstanding warrants or options.
Income Tax, Policy [Policy Text Block]	Income Taxes- Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company has determined that a valuation allowance is needed due to recent taxable net operating losses, the sale of profitable divisions and the limited taxable income in the carry back periods. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or expense in the period that includes the enactment date. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and certain tax loss carryforwards, less any valuation allowance. The Company accounts for uncertain tax positions as required in that a position taken or expected to be taken in a tax return is recognized in the consolidated financial statements when it is more likely than not (i.e., a likelihood of more than fifty percent) that the position would be sustained upon examination by tax authorities. A recognized tax position is then measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. The Company does not have any material unrecognized tax benefits. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as components of interest expense and other expense, respectively, in arriving at pretax income or loss. The Company does not have any interest and penalties accrued. The Company is generally no longer subject to U.S. federal, state, and local income tax examinations for the years before 2012.
Business Combinations Policy [Policy Text Block]	Business Combinations- ● future expected cash flows from product sales, support agreements, consulting contracts, other customer contracts, and acquired developed technologies and patents; and ● discount rates utilized in valuation estimates. Unanticipated events and circumstances may occur that may affect the accuracy or validity of such assumptions, estimates or actual results. Additionally, any change in the fair value of the acquisition-related contingent consideration subsequent to the acquisition date, including changes from events after the acquisition date, such as changes in our estimates of relevant revenue or other targets, will be recognized in earnings in the period of the estimated fair value change. A change in fair value of the acquisition-related contingent consideration or the occurrence of events that cause results to differ from our estimates or assumptions could have a material effect on the consolidated financial position, statements of operations or cash flows in the period of the change in the estimate.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Impairment of Long-Lived Assets-
Fair Value of Financial Instruments, Policy [Policy Text Block]	Financial Instruments and Fair Values- Level 1 – inputs include exchange quoted prices for identical instruments and are the most observable. Level 2 – inputs include brokered and/or quoted prices for similar assets and observable inputs such as interest rates. Level 3 – inputs include data not observable in the market and reflect management judgment about the assumptions market participants would use in pricing the asset or liability. The use of observable and unobservable inputs and their significant in measuring fair value are reflected in our hierarchy assessment. The carrying amount of cash, prepaid assets, accounts payable and accrued liabilities approximates fair value due to the short-term maturities of these instruments. Because cash and cash equivalents are readily liquidated, management classifies these values as Level 1. The fair value of the debentures, approximate their book value as the instruments are short-term in nature and contain market rates of interest. Because there is no ready market or observable transactions, management classifies the debentures as Level 3.
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued Accounting Standards-

Note 7 - Stock Options (Tables)

Note 7 - Stock Options (Tables)	9 Months Ended
	Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Share-based Compensation, Stock Options, Activity [Table Text Block]	A summary of options issued, exercised and cancelled are as follows: Shares Weighted- Average Exercise Price ($) Weighted- Average Remaining Contractual Term Aggregate Intrinsic Value ($) Outstanding at December 31, 2016 67,879 $ 21.40 6.17 — Granted — — — — Cancelled — — — — Outstanding at September 30, 2017 67,879 $ 21.40 5.42 — Exercisable at September 30, 2017 67,879 $ 21.40 5.42 —

Note 8 - Stock Warrants (Tables

Note 8 - Stock Warrants (Tables)	9 Months Ended
	Sep. 30, 2017
Disclosure Text Block Supplement [Abstract]
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	A summary of warrants issued, exercised and expired are as follows: Shares Weighted- Average Exercise Price ($) Weighted- Average Remaining Contractual Term Outstanding at December 31, 2016 142,653 $ 17.42 2.25 Granted — — — Expired — — — Outstanding at September 30, 2017 142,653 $ 17.42 1.50 Exercisable at September 30, 2017 142,653 $ 17.42 1.50

Note 1 - Description of Busin20

Note 1 - Description of Business (Details) - shares	Jan. 16, 2016	Sep. 30, 2017	Dec. 31, 2016
Disclosure Text Block [Abstract]
Stockholders' Equity, Reverse Stock Split	1 for 101
Common Stock, Shares Authorized		500,000,000	500,000,000
Preferred Stock, Shares Authorized		10,000,000	10,000,000

Note 2 - Summary of Significa21

Note 2 - Summary of Significant Accounting Policies (Details)	Jan. 16, 2016
Accounting Policies [Abstract]
Stockholders' Equity, Reverse Stock Split	1 for 101

Note 3 - Financial Condition 22

Note 3 - Financial Condition and Going Concern (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2016	Sep. 30, 2016	Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash and Cash Equivalents, at Carrying Value	$ 55	$ 0	$ 0	$ 28,185
Liabilities, Current	$ 1,245,993	$ 1,067,874

Note 4 - Related Party Transa23

Note 4 - Related Party Transactions (Details)	Sep. 26, 2017USD ($)shares	Aug. 23, 2017USD ($)shares	Aug. 10, 2017USD ($)shares	Aug. 07, 2017shares	Aug. 01, 2017shares	Jul. 07, 2017shares	Apr. 28, 2017shares	Mar. 08, 2017USD ($)$ / sharesshares	Feb. 14, 2017USD ($)$ / sharesshares	Feb. 07, 2017USD ($)shares	Jan. 25, 2017USD ($)shares	Jan. 24, 2017USD ($)shares	Dec. 30, 2016USD ($)shares	Sep. 30, 2016USD ($)shares	Sep. 27, 2016USD ($)shares	Sep. 23, 2016USD ($)shares	May 25, 2016USD ($)shares	Apr. 25, 2016shares	Jan. 25, 2016USD ($)shares	Sep. 30, 2017USD ($)	Sep. 30, 2017USD ($)shares	Sep. 30, 2016USD ($)	Dec. 31, 2016USD ($)shares	Dec. 30, 2016USD ($)	Jul. 10, 2017USD ($)
Note 4 - Related Party Transactions (Details) [Line Items]
Number of Board Members	2									1									2					2
Stock Issued During Period, Shares, Issued for Services (in Shares) | shares	400,000	30,000										25,000					100,000	100,000	100,000				4,070,000
Stock Issued During Period, Value, Issued for Services		$ 2,700										$ 3,500					$ 235,000		$ 145,000	$ 31,200	$ 109,710		$ 3,377,735
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares) | shares															1,000,000			1,000,000			0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period (in Shares) | shares																1,000,000
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares) | shares			500,000				500,000	100,000		100,000	500,000				100,000	100,000					100,000
Stock Issued During Period, Value, Restricted Stock Award, Gross								$ 30,000	$ 11,088	$ 11,000	$ 15,236		$ 57,240			$ 27,990
Number of Directors													3			3
Agreement, Monthly Amount														$ 10,000
Restricted Stock Award, Forfeitures															$ 2,000,000
Stock Issued During Period, Shares, Other (in Shares) | shares														966,666
Stock Issued During Period, Value, Other														$ 290,000							$ 3,750
Increase (Decrease) in Due to Related Parties														(290,000)							23,437	$ 77,284
Due to Related Parties, Current													$ 75,866							55,303	55,303		$ 106,866	$ 75,866
Stock Issued During Period, Shares, Share-based Compensation, Gross (in Shares) | shares	200,000												100,000
Stock Issued During Period, Value, Share-based Compensation, Gross													$ 19,080
Accounts Payable, Related Parties, Current													106,866											106,866
Accrued Salaries, Current													12,000											12,000
Due to Officers or Stockholders, Current													$ 7,000							33,333	$ 33,333			$ 7,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period							3 years		3 years		3 years
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures (in Shares) | shares					400,000	400,000
Stock Issued During Period, Shares, New Issues (in Shares) | shares										200,000											50,000		120,000
Proceeds from Issuance or Sale of Equity										$ 22,000											$ 47,000	51,000
Debt Conversion, Original Debt, Amount	$ 76,986								$ 20,000					$ 100,000							$ 0	103,671	$ 580,000
Share Price (in Dollars per share) | $ / shares								$ 0.30	$ 0.14
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares	987,000								142,857					400,000							228,571		1,066,666
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights							1/3 per year
Allocated Share-based Compensation Expense																					$ 48,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (in Shares) | shares						100,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (in Shares) | shares						400,000
Debt Instrument, Face Amount																									$ 75,000
Debt Instrument, Interest Rate, Stated Percentage																									12.00%
Stock Repurchased and Retired During Period, Shares (in Shares) | shares			2,150,000																		2,150,000
Stock Repurchased and Retired During Period, Value			$ 21,500
Stock to be Issued For Debt, Shares (in Shares) | shares	25,000			25,000																	987,000
Stock to be Issued For Debt																				3,573	$ 76,986	0
Interest Expense, Debt																				1,950
Share-based Compensation																				15,600	235,034	3,272,796
	$ 76,986																			$ 215,245	$ 215,245		$ 20,000
Shares to be Issued for Services (in Shares) | shares	200,000																				1,230,000
Issued to Each Director [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares) | shares													100,000
Stock Issued During Period, Value, Restricted Stock Award, Gross													$ 19,080
Director [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares) | shares																100,000
Stock Issued During Period, Value, Restricted Stock Award, Gross																$ 47,680
Agreement, Monthly Amount									$ 4,000
Stock Issued During Period, Shares, New Issues (in Shares) | shares																					250,000
Debt Conversion, Original Debt, Amount									$ 12,000
Share Price (in Dollars per share) | $ / shares									$ 0.14
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares									85,714
Former Chief Executive Officer [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Agreement, Monthly Amount															10,000
Advisory Board [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares) | shares								100,000
Stock Issued During Period, Value, Restricted Stock Award, Gross								$ 30,000
Share Price (in Dollars per share) | $ / shares								$ 0.30
Employment Agreement, Monthly Salary 2016 [Member] | Former Chief Executive Officer [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Agreement, Monthly Amount															12,500
Employment Agreement, Monthly Salary 2017 [Member] | Former Chief Executive Officer [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Agreement, Monthly Amount															17,500
Employment Agreement, Monthly Salary 2018 [Member] | Former Chief Executive Officer [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Agreement, Monthly Amount															22,500
Employment Agreement, Monthly Salary 2019 [Member] | Former Chief Executive Officer [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Agreement, Monthly Amount															$ 25,000
Advances to the Company [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Due to Related Parties, Current														$ 80,000								80,000
Consulting Fees [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Due to Related Parties, Current														120,000								120,000
Debt Conversion, Original Debt, Amount									$ 36,210
Share Price (in Dollars per share) | $ / shares									$ 0.14
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares									258,637
Costs Related to Acquisition [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Due to Related Parties, Current														$ 90,000								$ 90,000

Note 5 - Debt (Details)

Note 5 - Debt (Details) - USD ($)	Sep. 26, 2017	Aug. 10, 2017	Jul. 10, 2017	Feb. 14, 2017	Dec. 30, 2016	Sep. 30, 2016	Sep. 19, 2016	May 19, 2016	Mar. 18, 2016	Nov. 30, 2014	Aug. 31, 2014	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			12.00%
Debt Instrument, Face Amount			$ 75,000
Stock Issued During Period, Shares, Other (in Shares)						966,666
Stock Issued During Period, Shares, Conversion of Convertible Securities (in Shares)		25,000
Stock Issued During Period, Value, Conversion of Convertible Securities		$ 3,750												$ 32,000
Debt Conversion, Converted Instrument, Amount		7,860												32,000
Gains (Losses) on Restructuring of Debt		$ 4,110										$ 4,110	$ 0	4,110	$ 0
Interest Payable, Current												37,894		37,894		$ 31,021
Debt Instrument, Convertible, Beneficial Conversion Feature														0	9,375	67,062
Amortization of Debt Discount (Premium)														$ 0	157,947
Class of Warrant or Rights, Granted (in Shares)														0
Interest Expense, Debt												1,950
Stock Issued During Period, Value, Other						$ 290,000								$ 3,750
Debt Conversion, Original Debt, Amount	$ 76,986			$ 20,000		100,000								0	103,671	580,000
Gain (Loss) on Extinguishment of Debt						$ (16,329)						0	$ (16,329)	0	(206,329)	(190,000)
Debt Instrument, Maturity Date, Description			The July 2017 Note is due no later than 90 days after the receipt of a minimum of $1,000,000 of funding.
Convertible Note A [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage									12.00%
Debt Instrument, Face Amount									$ 60,000
Stock Issued During Period, Shares, Other (in Shares)							15,000		15,000
Shares Issued, Price Per Share (in Dollars per share)							$ 0.30
Debt Instrument, Fee Amount							$ 4,050
Interest Payable, Current												1,200		1,200		3,660
Debt Instrument, Periodic Payment									$ 1,000
Debt Instrument, Convertible, Conversion Price (in Dollars per share)									$ 1
Debt Instrument, Unamortized Discount									$ 18,750
Debt Instrument, Convertible, Beneficial Conversion Feature									$ 9,375
Amortization of Debt Discount (Premium)																28,125
Convertible Note B [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage								10.00%
Debt Instrument, Face Amount								$ 100,000
Stock Issued During Period, Shares, Other (in Shares)						400,000
Debt Instrument, Unamortized Discount								$ 100,000
Warrant Term								24 months
Class of Warrant or Rights, Granted (in Shares)								66,666
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)								$ 2.50
Warrants, Fair Value of Warrants, Granted								$ 103,086
Interest Expense, Debt								$ 3,086
Stock Issued During Period, Value, Other						$ 120,000
Gain (Loss) on Extinguishment of Debt															$ 16,329
Series C Debenture [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage											10.00%
Debt Instrument, Face Amount											$ 100,000
Debt Instrument, Convertible, Conversion Price (in Dollars per share)											$ 20.20
Warrant Term											5 years
Class of Warrant or Rights, Granted (in Shares)											4,950
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)											$ 20.20
Interest Expense, Debt														32,733		24,420
Convertible Debt											$ 110,833	110,833		110,833
Series D Debenture [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage										12.00%
Debt Instrument, Face Amount										$ 10,000
Debt Instrument, Convertible, Conversion Price (in Dollars per share)										$ 16.67
Warrant Term										5 years
Class of Warrant or Rights, Granted (in Shares)										495
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)										$ 20.20
Interest Expense, Debt														3,961		2,941
Convertible Debt										$ 11,333		$ 11,333		$ 11,333
P3 Compounding of Georgia, LLC [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage					10.50%
Debt Instrument, Face Amount																52,000
Debt Instrument, Fee Amount					$ 2,000											22,280
Debt Instrument, Periodic Payment					451.75
Debt Instrument, Unamortized Discount																22,280
Proceeds from Short-term Debt					$ 50,000
Debt Instrument, Term					160 days
Debt Instrument, Frequency of Periodic Payment					repayment amount of $451.75 per day
Short-term Debt					$ 72,280
Notes Payable																26,925
Principal [Member]
Note 5 - Debt (Details) [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities (in Shares)														50,000
Stock Issued During Period, Value, Conversion of Convertible Securities														$ 5,523
Debt Conversion, Original Debt, Amount						$ 3,671
Principal [Member] | Convertible Note B [Member]
Note 5 - Debt (Details) [Line Items]
Debt Conversion, Original Debt, Amount																100,000
Interest Expense [Member] | Convertible Note B [Member]
Note 5 - Debt (Details) [Line Items]
Debt Conversion, Original Debt, Amount																$ 3,671

Note 6 - Stockholders' Deficit

Note 6 - Stockholders' Deficit (Details)	Sep. 26, 2017USD ($)shares	Aug. 23, 2017USD ($)shares	Aug. 10, 2017USD ($)shares	Aug. 07, 2017shares	Feb. 14, 2017USD ($)shares	Feb. 07, 2017shares	Jan. 24, 2017USD ($)shares	Sep. 30, 2016USD ($)shares	May 25, 2016USD ($)shares	Apr. 25, 2016shares	Jan. 25, 2016USD ($)shares	Sep. 30, 2017USD ($)$ / shares	Sep. 30, 2016USD ($)	Sep. 30, 2017USD ($)$ / sharesshares	Sep. 30, 2016USD ($)	Dec. 31, 2016USD ($)$ / sharesshares
Note 6 - Stockholders' Deficit (Details) [Line Items]
Proceeds from Issuance of Common Stock																$ 60,000
Stock Issued During Period, Shares, New Issues (in Shares) | shares						200,000								50,000		120,000
Sale of Stock, Price Per Share (in Dollars per share) | $ / shares												$ 0.11		$ 0.11		$ 0.50
Payments of Stock Issuance Costs														$ 9,000
Stock Issued During Period, Shares, Issued for Services (in Shares) | shares	400,000	30,000					25,000		100,000	100,000	100,000					4,070,000
Stock Issued During Period, Value, Issued for Services		$ 2,700					$ 3,500		$ 235,000		$ 145,000	$ 31,200		$ 109,710		$ 3,377,735
Shares to be Issued for Services (in Shares) | shares	200,000													1,230,000
Stock to be Issued for Services, Value														$ 112,736
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares	987,000				142,857			400,000						228,571		1,066,666
Debt Conversion, Original Debt, Amount	$ 76,986				$ 20,000			$ 100,000						$ 0	$ 103,671	$ 580,000
Stock Issued During Period, Shares, Conversion of Convertible Securities (in Shares) | shares			25,000
Stock Issued During Period, Value, Conversion of Convertible Securities			$ 3,750											32,000
Debt Conversion, Converted Instrument, Amount			7,860											32,000
Gains (Losses) on Restructuring of Debt			$ 4,110									4,110	$ 0	4,110	0
Gain (Loss) on Extinguishment of Debt								(16,329)				0	$ (16,329)	$ 0	(206,329)	(190,000)
Stock to be Issued For Debt, Shares (in Shares) | shares	25,000			25,000										987,000
Stock to be Issued For Debt												3,573		$ 76,986	0
Proceeds from Convertible Debt														0	160,000	201,780
Debt Instrument, Convertible, Beneficial Conversion Feature														$ 0	$ 9,375	$ 67,062
Number of Notes														2
Common Stock, Value, Subscriptions												$ 10,000		$ 10,000
Stock Repurchased and Retired During Period, Shares (in Shares) | shares			2,150,000											2,150,000
Director [Member]
Note 6 - Stockholders' Deficit (Details) [Line Items]
Proceeds from Issuance of Common Stock														$ 47,000
Stock Issued During Period, Shares, New Issues (in Shares) | shares														250,000
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares					85,714
Debt Conversion, Original Debt, Amount					$ 12,000
Principal [Member]
Note 6 - Stockholders' Deficit (Details) [Line Items]
Debt Conversion, Original Debt, Amount								$ 3,671
Stock Issued During Period, Shares, Conversion of Convertible Securities (in Shares) | shares														50,000
Stock Issued During Period, Value, Conversion of Convertible Securities														$ 5,523
Accrued Interest [Member]
Note 6 - Stockholders' Deficit (Details) [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities (in Shares) | shares														25,000
Stock Issued During Period, Value, Conversion of Convertible Securities														$ 3,750
Debt Conversion, Converted Instrument, Amount														$ 7,860
Convertible Debt [Member]
Note 6 - Stockholders' Deficit (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares														15,000		15,000
Debt Conversion, Original Debt, Amount														$ 1,500		$ 18,750
Shares Issued for Services [Member]
Note 6 - Stockholders' Deficit (Details) [Line Items]
Stock Issued During Period, Shares, Issued for Services (in Shares) | shares														1,083,637
Stock Issued During Period, Value, Issued for Services														$ 123,498

Note 7 - Stock Options (Details

Note 7 - Stock Options (Details) - Share-based Compensation, Stock Options, Activity - USD ($)	Dec. 31, 2016	Sep. 27, 2016	Apr. 25, 2016	Sep. 30, 2017
Share-based Compensation, Stock Options, Activity [Abstract]
Options Outstanding, Shares	67,879
Options Outstanding, Weighted- Average Exercise Price	$ 21.40
Options Outstanding, Weighted- Average Remaining Contractual Term	6 years 62 days			5 years 153 days
Options Outstanding, Aggregate Intrinsic Value	$ 0			$ 0
Options Exercisable, Shares				67,879
Options Exercisable, Weighted- Average Exercise Price				$ 21.40
Options Exercisable, Weighted- Average Remaining Contractual Term				5 years 153 days
Options Exercisable, Aggregate Intrinsic Value				$ 0
Options Granted, Shares		1,000,000	1,000,000	0
Options Granted, Weighted- Average Exercise Price				$ 0
Options Cancelled, Shares				0
Options Cancelled, Weighted- Average Exercise Price				$ 0
Options Outstanding, Shares				67,879
Options Outstanding, Weighted- Average Exercise Price				$ 21.40

Note 8 - Stock Warrants (Detail

Note 8 - Stock Warrants (Details)	Jan. 16, 2016
Disclosure Text Block Supplement [Abstract]
Stockholders' Equity, Reverse Stock Split	1 for 101

Note 8 - Stock Warrants (Deta28

Note 8 - Stock Warrants (Details) - Schedule of Stockholders' Equity Note, Warrants or Rights - $ / shares	Dec. 31, 2016	Sep. 30, 2017
Schedule of Stockholders' Equity Note, Warrants or Rights [Abstract]
Warrants, Outstanding	142,653
Warrants, Outstanding Weighted-Average Exercise Price	$ 17.42	$ 17.42
Warrants, Outstanding Weighted-Average Remaining Contractual Terms	2 years 3 months	1 year 6 months
Warrants, Exercisable		142,653
Warrants, Exercisable Weighted-Average Exercise Price		$ 17.42
Warrants, Exercisable Weighted-Average Remaining Contractual Terms		1 year 6 months
Warrants, Granted		0
Warrants, Granted Weighted-Average Exercise Price		$ 0
Warrants, Expired		0
Warrants, Expired Weighted-Average Exercise Price		$ 0
Warrants, Outstanding		142,653

Note 9 - Commitments and Cont29

Note 9 - Commitments and Contingencies (Details) - USD ($)	May 18, 2017	Nov. 04, 2016	Sep. 23, 2016	Dec. 16, 2015	Sep. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
Loss Contingency, Damages Sought				The complaint seeks damages in the amount of $177,270, inclusive of attorney’s fees, costs and accrued interest, continuing interest in the amount of 12% per annum and attorney’s fees and costs of collection relating to the case.
Loss Contingency, Damages Sought, Value	$ 241,828			$ 177,270
Loss Contingency, Damages Awarded, Value		$ 75,000	$ 48,500
Settlement Liabilities, Current					$ 75,000
Estimated Litigation Liability, Current					241,828
Litigation Settlement, Expense					$ 20,000

Note 10 - Subsequent Events (De

Note 10 - Subsequent Events (Details) - shares	Nov. 19, 2017	Aug. 10, 2017	Apr. 28, 2017	Mar. 08, 2017	Feb. 07, 2017	Jan. 25, 2017	Sep. 27, 2016	Sep. 23, 2016	Sep. 30, 2017
Note 10 - Subsequent Events (Details) [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross		500,000	500,000	100,000	100,000	500,000	100,000	100,000	100,000
Subsequent Event [Member]
Note 10 - Subsequent Events (Details) [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Gross	80,000